Feb 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.56 10.33 13.10
(-26.6 pct)
Operating loss 505 mln loss 147 mln loss 380 mln
Recurring loss 480 mln loss 147 mln loss 360 mln
Net loss 529 mln loss 87 mln loss 380 mln
EPS loss 139.98 yen loss 23.03 yen loss 100.49 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T